Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

Regulatory Consulting Services Framework

  • First published: 04 February 2019
  • Last modified: 04 February 2019
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
Published by:
NHS South West — Acutes
Authority ID:
AA32907
Publication date:
04 February 2019
Deadline date:
01 March 2019
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Author a CMC Module 3 and Module 2.3 Quality Overall Summary (the majority of the 3.2.S and 2.3.S sections will consist of an ASMF or CEP as supplied by TP).

Full notice text

Contract notice

Section I: Contracting authority

I.1) Name and addresses

NHS South West - Acutes

1234

Wilkins Drive

Paignton

TQ4 7FG

UK

Contact person: Ashley Noyce

Telephone: +44 1803660040

E-mail: ashleynoyce@nhs.net

NUTS: UKK

Internet address(es)

Main address: www.torbaypharmaceuticals.nhs.uk

Address of the buyer profile: https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/45644

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=27146&B=NHSSW


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=27146&B=NHSSW


Tenders or requests to participate must be sent to the abovementioned address


I.4) Type of the contracting authority

Regional or local authority

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Regulatory Consulting Services Framework

II.1.2) Main CPV code

73000000

 

II.1.3) Type of contract

Services

II.1.4) Short description

One of the main strategic business aims of Torbay Pharmaceuticals is to increase the number of licensed products held by TP. To support this strategy a programme of products for licensing (which are currently manufactured by TP) has been created. Individual projects will be outsourced to regulatory consultants to project manage the generation of a MAA for filing into the regulatory agencies identified from the regulatory strategy for the individual product.

II.1.5) Estimated total value

Value excluding VAT: 200 000.00  GBP

II.1.6) Information about lots

This contract is divided into lots: Yes

Tenders may be submitted for all lots

The contracting authority reserves the right to award contracts combining the following lots or groups of lots:

All lots.

II.2) Description

Lot No: 1

II.2.1) Title

Author a CMC Module 3

II.2.2) Additional CPV code(s)

73200000

73220000

79900000

79990000

II.2.3) Place of performance

NUTS code:

UKK

UK

II.2.4) Description of the procurement

Author a CMC Module 3 and Module 2.3 Quality Overall Summary (the majority of the 3.2.S and 2.3.S sections will consist of an ASMF or CEP as supplied by TP).

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

Attached as document.

Lot No: 2

II.2.1) Title

Lot 2: Author a CMC Module 3 and Module 2.3 Quality Overall Summary

II.2.2) Additional CPV code(s)

73200000

73220000

79900000

79990000

II.2.3) Place of performance

NUTS code:

UKK

II.2.4) Description of the procurement

Author a non-clinical Module 4 and Module 2.4 and 2.6 non-clinical overview and summary including the EU based signed expert statement

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

Attached as document.

Lot No: 3

II.2.1) Title

Lot 3: Author a Non-Clinical Module 4 and Module 2.4 and 2.6 Non-Clinical Overview and Summary

II.2.2) Additional CPV code(s)

73200000

73220000

79900000

79990000

II.2.3) Place of performance

NUTS code:

UKK

II.2.4) Description of the procurement

Author a clinical Module 5 and Module 2.5 and 2.7 clinical overview and summary including the EU based signed expert statement.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

Attached as document.

Lot No: 4

II.2.1) Title

Lot 4: Author a Clinical Module 5 and Module 2.5 and 2.7 Clinical Overview

II.2.2) Additional CPV code(s)

73200000

73220000

79900000

79990000

II.2.3) Place of performance

NUTS code:

UKK

II.2.4) Description of the procurement

Author a CTD Module 1 including RMP, SPC/PIL and annexes.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

Attached as document.

Lot No: 5

II.2.1) Title

Lot 5: Autjor a CTD Module 1 including RMP, SPC/PIL and Annexes

II.2.2) Additional CPV code(s)

73200000

73220000

79900000

79990000

II.2.3) Place of performance

NUTS code:

UKK

II.2.4) Description of the procurement

Author variations (Type 1A, 1B and II) to existing approved MA’s (UK, EU and global).

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

Attached as document.

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents


III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


III.2) Conditions related to the contract

III.2.2) Contract performance conditions

As per Tender Document and negotiated T and Cs

III.2.3) Information about staff responsible for the performance of the contract

Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement with several operators.

Envisaged maximum number of participants to the framework agreement: 5

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 01/03/2019

Local time: 12:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.6) Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 01/04/2019

IV.2.7) Conditions for opening of tenders

Date: 01/03/2019

Local time: 12:00

Place:

Torbay Pharmaceuticals, Paignton, Devon, TQ4 7FG.

Information about authorised persons and opening procedure:

Procurement Department x 2.

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: Yes

Estimated timing for further notices to be published:

3 years.

VI.2) Information about electronic workflows

Electronic payment will be used

VI.4) Procedures for review

VI.4.1) Review body

Ashley Noyce

Paignton

UK

VI.4.2) Body responsible for mediation procedures

Ashley Noyce

Paignton

UK

VI.4.4) Service from which information about the review procedure may be obtained

Ashley Noyce

Paignton

UK

VI.5) Date of dispatch of this notice

31/01/2019

Coding

Commodity categories

ID Title Parent category
73220000 Development consultancy services Research and development consultancy services
79900000 Miscellaneous business and business-related services Business services: law, marketing, consulting, recruitment, printing and security
79990000 Miscellaneous business-related services Miscellaneous business and business-related services
73200000 Research and development consultancy services Research and development services and related consultancy services
73000000 Research and development services and related consultancy services Research and Development

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
ashleynoyce@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.